1. Home
  2. CASI vs DTST Comparison

CASI vs DTST Comparison

Compare CASI & DTST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASI
  • DTST
  • Stock Information
  • Founded
  • CASI 1991
  • DTST 2001
  • Country
  • CASI China
  • DTST United States
  • Employees
  • CASI N/A
  • DTST N/A
  • Industry
  • CASI Biotechnology: Pharmaceutical Preparations
  • DTST EDP Services
  • Sector
  • CASI Health Care
  • DTST Technology
  • Exchange
  • CASI Nasdaq
  • DTST Nasdaq
  • Market Cap
  • CASI 35.8M
  • DTST 32.6M
  • IPO Year
  • CASI 1996
  • DTST N/A
  • Fundamental
  • Price
  • CASI $2.01
  • DTST $4.74
  • Analyst Decision
  • CASI Strong Buy
  • DTST
  • Analyst Count
  • CASI 1
  • DTST 0
  • Target Price
  • CASI $4.00
  • DTST N/A
  • AVG Volume (30 Days)
  • CASI 76.1K
  • DTST 69.0K
  • Earning Date
  • CASI 11-13-2025
  • DTST 11-13-2025
  • Dividend Yield
  • CASI N/A
  • DTST N/A
  • EPS Growth
  • CASI N/A
  • DTST N/A
  • EPS
  • CASI N/A
  • DTST N/A
  • Revenue
  • CASI $31,564,000.00
  • DTST $25,455,742.00
  • Revenue This Year
  • CASI N/A
  • DTST $12.57
  • Revenue Next Year
  • CASI N/A
  • DTST $9.29
  • P/E Ratio
  • CASI N/A
  • DTST N/A
  • Revenue Growth
  • CASI 36.64
  • DTST 0.53
  • 52 Week Low
  • CASI $1.09
  • DTST $2.93
  • 52 Week High
  • CASI $7.50
  • DTST $5.44
  • Technical
  • Relative Strength Index (RSI)
  • CASI 50.04
  • DTST 60.80
  • Support Level
  • CASI N/A
  • DTST $4.52
  • Resistance Level
  • CASI $2.49
  • DTST $4.72
  • Average True Range (ATR)
  • CASI 0.17
  • DTST 0.12
  • MACD
  • CASI -0.14
  • DTST 0.01
  • Stochastic Oscillator
  • CASI 80.40
  • DTST 84.21

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About DTST Data Storage Corporation

Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.

Share on Social Networks: